Health and Fitness Health and Fitness
Mon, May 7, 2012
Sat, May 5, 2012
Fri, May 4, 2012
Thu, May 3, 2012
[ Thu, May 03rd 2012 ] - Market Wire
00 p.m. EDT
Wed, May 2, 2012
[ Wed, May 02nd 2012 ] - Market Wire
Location Change
Tue, May 1, 2012
Mon, April 30, 2012
[ Mon, Apr 30th 2012 ] - Market Wire
Hologic to Acquire Gen-Probe
Sun, April 29, 2012
Sat, April 28, 2012
Fri, April 27, 2012
Thu, April 26, 2012
Wed, April 25, 2012
Tue, April 24, 2012
Mon, April 23, 2012

Cambrex To Announce First Quarter 2012 Financial Results On May 3, 2012


//health-fitness.news-articles.net/content/2012/ .. uarter-2012-financial-results-on-may-3-2012.html
Published in Health and Fitness on Friday, April 27th 2012 at 7:46 GMT by Market Wire   Print publication without navigation


Cambrex To Announce First Quarter 2012 Financial Results On May 3,... -- EAST RUTHERFORD, N.J., April 27, 2012 /PRNewswire/ --

Cambrex To Announce First Quarter 2012 Financial Results On May 3, 2012

[ ]

EAST RUTHERFORD, N.J., April 27, 2012/PRNewswire/ -- Cambrex Corporation (NYSE: [ CBM ]) announced that first quarter 2012 financial results will be released on Thursday, May 3, 2012 after the market closes.

The Company will host a conference call to discuss the first quarter 2012 financial results.

cellpadding="0" cellspacing="0" id="convertedTable" style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; BORDER-COLLAPSE: collapse; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">

First Quarter 2012 Earnings Conference Call



When:

Friday, May 4, 2012 at 8:30 a.m. Eastern Time



Dial-in: 

1-800-499-7921 for U.S.


1-719-325-2412 for International 


Passcode:  8201647



Dial-in Replay:

1-888-203-1112 for U.S.


1-719-457-0820 for International


Passcode:  8201647


Available through Friday, May 11, 2012



Webcast: 

[ www.cambrex.com ]


Available for 30 days following the conference call

About Cambrex

Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  We offer Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products.  For more information, please visit [ www.cambrex.com ]. 

SOURCE Cambrex Corporation

[ Back to top ]

RELATED LINKS
[ http://www.cambrex.com ]


Publication Contributing Sources